FPR2/ALXR agonists (Actelion Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFPR2/ALXR agonists (Actelion Pharmaceuticals)
Drug Alias NameACT-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN-formyl peptide receptor 2 agonists
TargetsN-formyl peptide receptor 2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActelion Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A